Alterity Therapeutics Limited
ASX:ATH.AX
0.003 (AUD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4.019 | 3.916 | 5.124 | 4.34 | 0 | 0.109 | 0.201 | 0.132 | 0.143 | 0.177 | 0.364 | 0.151 | 0.187 | 0.156 | 0.215 | 0.428 | 0.492 | 0.507 | 0.762 | 2.642 | 2.307 | 1.811 | 0.794 | 0.516 | 0.079 | 0 | 0 |
| Cost of Revenue
| 0.214 | 0.285 | 0.365 | 0.36 | 0.112 | 0.03 | 0.022 | 0.021 | 0.023 | 0.257 | -7.845 | -4.338 | 0 | 0.399 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 3.805 | 3.631 | 4.759 | 3.98 | -0.112 | 0.079 | 0.179 | 0.111 | 0.12 | -0.08 | 8.209 | 4.489 | 0.187 | -0.243 | 0.215 | 0.428 | 0.492 | 0.507 | 0.762 | 2.642 | 2.307 | 1.811 | 0.794 | 0.516 | 0.079 | 0 | 0 |
| Gross Profit Ratio
| 0.947 | 0.927 | 0.929 | 0.917 | 0 | 0.726 | 0.892 | 0.839 | 0.84 | -0.455 | 22.567 | 29.752 | 1 | -1.557 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Reseach & Development Expenses
| 18.644 | 13.199 | 14.746 | 12.284 | 10.098 | 12.983 | 6.698 | 5.7 | 9.585 | 12.298 | 14.908 | 7.946 | 4.229 | 2.329 | 0.088 | 2.215 | 5.77 | 4.491 | 7.618 | 7.656 | 5.201 | 1.856 | 2.481 | 2.376 | 0.422 | 0 | 0 |
| General & Administrative Expenses
| 4.772 | 4.988 | 5.435 | 6.85 | 3.334 | 4.279 | 4.319 | 3.947 | 3.588 | 4.06 | 3.09 | 3.116 | 0.507 | 3.565 | 3.922 | 5.266 | 6.298 | 6.732 | 4.305 | 8.286 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| -0.01 | 0.051 | 0.079 | 0.022 | 0 | 0 | 0 | 0 | 0 | 0.088 | 0.359 | 0.136 | 0.125 | 0.111 | 0.13 | 0.223 | 0.141 | 0.215 | 0.135 | 0.441 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4.763 | 5.039 | 5.514 | 6.872 | 3.334 | 4.279 | 4.319 | 3.947 | 3.588 | 4.148 | 3.449 | 3.252 | 0.632 | 3.676 | 4.052 | 5.488 | 7.431 | 6.948 | 4.44 | 5.633 | 4.808 | 2.565 | 2.147 | 0 | 0 | 0 | 0 |
| Other Expenses
| 0 | -0.283 | -0.365 | -0.36 | -3.363 | -4.789 | 2.901 | -0.242 | -0.242 | -0.171 | -0.507 | -0.421 | 0.02 | 0.032 | 0.976 | 1.013 | 7.456 | 0.059 | 0.118 | 6.793 | 5.996 | 3.748 | 3.309 | 1.141 | 0 | -0.08 | -0.001 |
| Operating Expenses
| 23.407 | 17.35 | 17.538 | 19.31 | 10.069 | 12.473 | 11.097 | 6.772 | 8.488 | 10.612 | 12.409 | 7.64 | 7.846 | 6.037 | 5.116 | 8.717 | 13.226 | 11.497 | 12.176 | 14.45 | 11.197 | 5.604 | 5.79 | 3.517 | 0.422 | -0.08 | -0.001 |
| Operating Income
| -19.602 | -14.636 | -15.502 | -15.179 | -10.414 | -12.714 | -7.77 | -6.882 | -8.587 | -10.436 | -12.552 | -7.802 | -5.319 | -6.277 | -4.901 | -8.288 | -12.734 | -10.99 | -11.413 | -11.807 | -8.89 | -3.792 | -4.996 | -3.001 | -0.343 | -0.08 | -0.001 |
| Operating Income Ratio
| -4.877 | -3.737 | -3.026 | -3.498 | 0 | -117.137 | -38.625 | -51.979 | -60.192 | -59.011 | -34.506 | -51.714 | -28.493 | -40.202 | -22.794 | -19.357 | -25.882 | -21.676 | -14.969 | -4.469 | -3.853 | -2.094 | -6.289 | -5.814 | -4.357 | 0 | 0 |
| Total Other Income Expenses Net
| 0.524 | 0.934 | 2.725 | -0.131 | 0.354 | 0.376 | 2.63 | -0.902 | 0.615 | 4.55 | -1.254 | -0.28 | 0.079 | -0.154 | -0.006 | 0.766 | -0.856 | -0.15 | -0.313 | -12.473 | -0.936 | -0.779 | -0.456 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -19.077 | -13.702 | -12.777 | -15.309 | -10.06 | -12.338 | -8.266 | -7.542 | -7.73 | -5.885 | -13.329 | -7.787 | -5.239 | -6.431 | -4.907 | -7.523 | -13.59 | -11.14 | -11.726 | -24.907 | -9.826 | -4.571 | -5.451 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -4.746 | -3.499 | -2.494 | -3.528 | 0 | -113.673 | -41.088 | -56.966 | -54.183 | -33.279 | -36.641 | -51.617 | -28.069 | -41.19 | -22.822 | -17.569 | -27.622 | -21.97 | -15.379 | -9.426 | -4.259 | -2.524 | -6.862 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.046 | 0.104 | 0.07 | -4.126 | -0.362 | -0.376 | -0.495 | 0.66 | -0.857 | -0.171 | -0.477 | -0.403 | -2.42 | 0.004 | 0.006 | -0.766 | 0.856 | 0.15 | 0.313 | 13.1 | 0.936 | 0.779 | 0.456 | 1.138 | 1.326 | 0.08 | 0.001 |
| Net Income
| -19.123 | -13.807 | -12.847 | -15.309 | -9.697 | -11.962 | -8.266 | -7.542 | -7.73 | -5.885 | -13.329 | -7.787 | -5.239 | -6.431 | -4.907 | -7.523 | -13.59 | -11.14 | -11.726 | -24.907 | -9.826 | -4.571 | -5.451 | -4.139 | -1.326 | -0.08 | -0.001 |
| Net Income Ratio
| -4.758 | -3.525 | -2.507 | -3.528 | 0 | -110.208 | -41.088 | -56.966 | -54.183 | -33.279 | -36.641 | -51.617 | -28.069 | -41.19 | -22.822 | -17.569 | -27.622 | -21.97 | -15.379 | -9.426 | -4.259 | -2.524 | -6.862 | -8.018 | -16.84 | 0 | 0 |
| EPS
| -0.005 | -0.006 | -0.005 | -0.009 | -0.011 | -0.019 | -0.016 | -0.014 | -0.015 | -0.012 | -0.031 | -0.023 | -0.018 | -0.026 | -0.022 | -0.037 | -0.078 | -0.079 | -0.092 | -0.2 | -0.13 | -0.08 | -0.1 | -0.08 | -0.04 | -0.02 | 0 |
| EPS Diluted
| -0.005 | -0.006 | -0.005 | -0.009 | -0.011 | -0.019 | -0.016 | -0.014 | -0.015 | -0.012 | -0.031 | -0.023 | -0.018 | -0.026 | -0.022 | -0.037 | -0.078 | -0.079 | -0.092 | -0.2 | -0.13 | -0.08 | -0.1 | -0.08 | -0.04 | -0.02 | 0 |
| EBITDA
| -19.572 | -14.598 | -15.484 | -15.16 | -10.302 | -12.684 | -10.603 | -5.958 | -9.179 | -10.575 | -12.53 | -7.887 | -7.719 | -6.242 | -4.859 | -9.02 | -11.852 | -10.782 | -10.982 | 1.826 | -6.766 | -1.831 | -3.378 | -1.86 | -0.343 | -0.08 | -0.001 |
| EBITDA Ratio
| -4.869 | -3.728 | -3.022 | -3.493 | 0 | -116.864 | -52.708 | -45.005 | -64.345 | -59.799 | -34.445 | -52.279 | -41.352 | -39.976 | -22.601 | -21.065 | -24.09 | -21.265 | -14.403 | 0.691 | -2.933 | -1.011 | -4.253 | -3.604 | -4.357 | 0 | 0 |